Lupin gets USFDA nod for generic risperidone extended-release injectable suspension
Pharma major Lupin Ltd on Wednesday said it has received approval from the US health regulator for its generic version of risperidone for extended-release injectable suspension, used in the treatment and maintenance of schizophrenia and bipolar disorder in adults. The approval by the US Food and Drug Administration (USFDA) is for the abbreviated new drug…